These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 8161111

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment.
    Fujimoto N, Teramura K, Tanaka T.
    J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inflammation at a previous inoculation site: an unusual presentation of Kawasaki disease.
    Weinstein M.
    CMAJ; 2006 Feb 14; 174(4):459-60. PubMed ID: 16477055
    [No Abstract] [Full Text] [Related]

  • 6. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.
    Kuo HC, Wang CL, Wang L, Yu HR, Yang KD.
    Pediatr Allergy Immunol; 2008 Mar 14; 19(2):184-5. PubMed ID: 18257906
    [No Abstract] [Full Text] [Related]

  • 7. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.
    Kobayashi T, Kimura H, Okada Y, Inoue Y, Kobayashi T, Shinohara M, Morikawa A.
    Clin Exp Immunol; 2007 Apr 14; 148(1):112-8. PubMed ID: 17286760
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A, Moszyńska B, Pawłowska-Kamieniak A, Szczepanowska A, Papierkowski A.
    Pol Merkur Lekarski; 1997 Jul 14; 3(13):20-1. PubMed ID: 9432293
    [Abstract] [Full Text] [Related]

  • 11. [Kawasaki syndrome in adults: treatment with polyvalent intravenous immunoglobulins].
    Pavese P, Brion JP, Meusnier T, Stahl JP.
    Ann Med Interne (Paris); 1997 Jul 14; 148(3):287-8. PubMed ID: 9255342
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage.
    Singh S, Kumar L.
    Indian Pediatr; 1996 Aug 14; 33(8):689-92. PubMed ID: 8979554
    [No Abstract] [Full Text] [Related]

  • 14. IVIG, aspirin, and Kawasaki disease.
    Morgan GJ, MacLeod C, Jenkins J, Stewart C, Craig B.
    J Pediatr; 2003 Aug 14; 143(2):280-1; author reply 281. PubMed ID: 12970651
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kawasaki disease in Calcutta.
    Paul DK, Gupta A, Lahiri M.
    Indian Pediatr; 2000 Nov 14; 37(11):1264-5. PubMed ID: 11086312
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.
    Leung DY.
    Clin Rev Allergy; 1992 Nov 14; 10(1-2):93-104. PubMed ID: 1606527
    [No Abstract] [Full Text] [Related]

  • 19. [New aspects of therapy in Kawasaki disease].
    Keren G, Ballin A.
    Harefuah; 1994 Jun 01; 126(11):667-71. PubMed ID: 7927003
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
    Chaker L, Drissa MA, Drissa H.
    Tunis Med; 2009 Mar 01; 87(3):228-9. PubMed ID: 19537024
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.